Despite looming US tariff threats on imported generics, global pharma companies, led by smaller emerging Indian firms, have accelerated Abbreviated New Drug Application (ANDA) filings, focusing heavily on high-margin complex generics like inhalers and injectables. In trade developments, India secured zero-duty market access for over 90% of its steel exports to the EU, while establishing carbon emission verification framework discussions under the Carbon Border Adjustment Mechanism (CBAM). India’s marine product exports also posted strong momentum, growing 14.3% year-on-year during April–August FY27 to reach $3.65 billion, propelled by steady US demand for frozen shrimp and market diversification into Europe and Asia. On the diplomatic front, Tamil Nadu Chief Minister C. Joseph Vijay concluded a successful official visit to the United Kingdom, securing investment MoUs worth ₹15,300 crore expected to generate over 10,000 jobs in aerospace, logistics, and textiles. Finally, India welcomed the New Zealand Parliament’s ratification of the India-New Zealand Free Trade Agreement, which grants duty-free access for 100% of Indian export lines and establishes a framework to facilitate $20 billion in bilateral investment.